Guidance

The Risk Sharing Scheme for Disease Modifying Therapies in MS

The purpose of this leaflet is to give an update on progress with the Risk Sharing Scheme for Disease Modifying Therapies (DMTs) in Multiple Sclerosis.

Documents

The Risk Sharing Scheme for Disease Modifying Therapies in MS

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Equality impact assessment

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The Risk Sharing Scheme for Disease Modifying Therapies in MS (2007 edition)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

This leaflet aims to provide an overview of the scheme: who is involved; how it is run; how the data collated will be used and the benefits of the scheme for management of MS in the UK.